Breaking News Instant updates and real-time market news.

BX

Blackstone

$62.75 /

-0.24 (-0.38%)

08:52
02/10/20
02/10
08:52
02/10/20
08:52

Blackstone price target raised to $72 from $60 at Argus

Argus analyst Stephen Biggar raised his price target on Blackstone to $72 and kept his Buy rating after its Q4 earnings beat, saying the company also benefited from a "more favorable environment" for realization while its fee-based earnings also continued to expand. The analyst adds that the company's conversion from a partnership to a corporation will also support Blackstone shares by allowing the stock to be included in a wider range of indices.

  • 26

    Feb

BX Blackstone
$62.75 /

-0.24 (-0.38%)

01/31/20 BMO Capital
Blackstone price target raised to $53 from $47 at BMO Capital
01/13/20 Credit Suisse
Brookfield price target raised to $68 from $60 at Credit Suisse
12/19/19 Wells Fargo
Wells stays bullish on alternative asset managers into 2020, Ares top pick
11/01/19
Rice University-Jones Graduate School of Business to hold a summit

TODAY'S FREE FLY STORIES

Options
Aercap call volume above normal and directionally bullish » 15:25
05/26/20
05/26
15:25
05/26/20
15:25
AER

AerCap

$30.73 /

+1.89 (+6.55%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AER AerCap
$30.73 /

+1.89 (+6.55%)

AER AerCap
$30.73 /

+1.89 (+6.55%)

09:22 Today JPMorgan
JPMorgan upgrades Fly Leasing with stock rally lagging peers
05/06/20 Deutsche Bank
AerCap price target lowered to $44 from $63 at Deutsche Bank
05/06/20 Deutsche Bank
AerCap price target lowered to $44 from $63 at Deutsche Bank
05/06/20 Barclays
AerCap price target raised to $39 from $32 at Barclays
AER AerCap
$30.73 /

+1.89 (+6.55%)

AER AerCap
$30.73 /

+1.89 (+6.55%)

AER AerCap
$30.73 /

+1.89 (+6.55%)

Options
HEICO options imply 5.6% move in share price post-earnings » 15:19
05/26/20
05/26
15:19
05/26/20
15:19
HEI

Heico

$100.04 /

+6.13 (+6.53%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HEI Heico
$100.04 /

+6.13 (+6.53%)

HEI Heico
$100.04 /

+6.13 (+6.53%)

05/18/20 Canaccord
Heico downgraded to Hold at Canaccord
05/18/20 Canaccord
Heico downgraded to Hold from Buy at Canaccord
03/31/20 Jefferies
Heico downgraded to Hold from Buy at Jefferies
03/30/20 Vertical Research
Heico downgraded to Hold from Buy at Vertical Research
HEI Heico
$100.04 /

+6.13 (+6.53%)

HEI Heico
$100.04 /

+6.13 (+6.53%)

HEI Heico
$100.04 /

+6.13 (+6.53%)

Technical Analysis
NASDAQ market internals summary » 15:17
05/26/20
05/26
15:17
05/26/20
15:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 15:16
05/26/20
05/26
15:16
05/26/20
15:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Recommendations
BMO Capital still sees favorable risk/reward in Alexion following Argenx news » 15:15
05/26/20
05/26
15:15
05/26/20
15:15
ALXN

Alexion

$104.30 /

+2.76 (+2.72%)

, ARGX

Argenx

$213.67 /

+55.405 (+35.01%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALXN Alexion
$104.30 /

+2.76 (+2.72%)

ARGX Argenx
$213.67 /

+55.405 (+35.01%)

ALXN Alexion
$104.30 /

+2.76 (+2.72%)

11:47 Today Piper Sandler
Piper stays Overweight Alexion after Argenx data, says comps 'near impossible'
07:25 Today Credit Suisse
Skepticism may create overlooked value in Alexion pipeline, says Credit Suisse
05/15/20 H.C. Wainwright
H.C. Wainwright calls Sarepta 'best of breed' after Pfizer DMD data
05/06/20 Piper Sandler
Piper Sandler remains buyer of Alexion despite frustration
ARGX Argenx
$213.67 /

+55.405 (+35.01%)

14:49 Today JMP Securities
Argenx price target raised to $237 from $170 at JMP Securities
14:20 Today Stifel
Argenx price target raised to $253 from $163 at Stifel
11:47 Today Piper Sandler
Piper stays Overweight Alexion after Argenx data, says comps 'near impossible'
08:01 Today Stifel
Argenx's results in MG should read through positively for Momenta, says Stifel
ALXN Alexion
$104.30 /

+2.76 (+2.72%)

ALXN Alexion
$104.30 /

+2.76 (+2.72%)

ALXN Alexion
$104.30 /

+2.76 (+2.72%)

ARGX Argenx
$213.67 /

+55.405 (+35.01%)

ALXN Alexion
$104.30 /

+2.76 (+2.72%)

Conference/Events
Varonis participates in a conference call with JMP Securities » 15:15
05/26/20
05/26
15:15
05/26/20
15:15
VRNS

Varonis

$82.99 /

+2.56 (+3.18%)

Cybersecurity & IT…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRNS Varonis
$82.99 /

+2.56 (+3.18%)

VRNS Varonis
$82.99 /

+2.56 (+3.18%)

05/05/20 DA Davidson
Varonis price target raised to $85 from $65 at DA Davidson
05/05/20 Craig-Hallum
Varonis downgraded to Hold at Craig-Hallum
05/05/20 Wedbush
Varonis price target lowered to $88 from $105 at Wedbush
05/05/20 Craig-Hallum
Varonis downgraded to Hold from Buy at Craig-Hallum
VRNS Varonis
$82.99 /

+2.56 (+3.18%)

VRNS Varonis
$82.99 /

+2.56 (+3.18%)

Recommendations
Anaplan price target raised to $51 from $38 at Piper Sandler » 15:14
05/26/20
05/26
15:14
05/26/20
15:14
PLAN

Anaplan

$47.75 /

-3.32 (-6.50%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLAN Anaplan
$47.75 /

-3.32 (-6.50%)

PLAN Anaplan
$47.75 /

-3.32 (-6.50%)

15:02 Today Piper Sandler
Piper Sandler would be buyers on Anaplan weakness following earnings
14:55 Today Goldman Sachs
Anaplan should benefit as macro situation improves, says Goldman Sachs
13:05 Today Rosenblatt
Rosenblatt says Anaplan reliance on large projects 'clearly impacting' business
05/21/20 RBC Capital
Anaplan price target raised to $55 from $51 at RBC Capital
PLAN Anaplan
$47.75 /

-3.32 (-6.50%)

PLAN Anaplan
$47.75 /

-3.32 (-6.50%)

PLAN Anaplan
$47.75 /

-3.32 (-6.50%)

Hot Stocks
MoneyGram announces launch of Uber partnership » 15:10
05/26/20
05/26
15:10
05/26/20
15:10
MGI

MoneyGram

$1.96 /

+0.04 (+2.09%)

, UBER

Uber

$34.90 /

+0.07 (+0.20%)

MoneyGram International…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MGI MoneyGram
$1.96 /

+0.04 (+2.09%)

UBER Uber
$34.90 /

+0.07 (+0.20%)

MGI MoneyGram
$1.96 /

+0.04 (+2.09%)

04/06/20 Barclays
MoneyGram price target lowered to $1 from $2 at Barclays
04/03/20 Northcoast
Northcoast cuts estimates for MoneyGram and Western Union
03/24/20 Northland
Northland downgrades MoneyGram to Market Perform on coronavirus lockdowns
03/24/20 Northland
MoneyGram downgraded to Market Perform from Outperform at Northland
UBER Uber
$34.90 /

+0.07 (+0.20%)

11:17 Today Wolfe Research
Uber upgraded to Outperform from Peer Perform at Wolfe Research
05/15/20 Wedbush
Uber's potential GrubHub deal an offensive and defensive move, says Wedbush
05/15/20 Citi
Citi boosts Uber target to $41, Lyft target to $50
05/13/20 KeyBanc
KeyBanc says NYC regulatory risk should be considered by food delivery investors
MGI MoneyGram
$1.96 /

+0.04 (+2.09%)

UBER Uber
$34.90 /

+0.07 (+0.20%)

UBER Uber
$34.90 /

+0.07 (+0.20%)

UBER Uber
$34.90 /

+0.07 (+0.20%)

MGI MoneyGram
$1.96 /

+0.04 (+2.09%)

UBER Uber
$34.90 /

+0.07 (+0.20%)

Options
Keysight Technologies options imply 9.7% move in share price post-earnings » 15:04
05/26/20
05/26
15:04
05/26/20
15:04
KEYS

Keysight Technologies

$104.35 /

+2.21 (+2.16%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KEYS Keysight Technologies
$104.35 /

+2.21 (+2.16%)

KEYS Keysight Technologies
$104.35 /

+2.21 (+2.16%)

04/14/20 JPMorgan
Keysight Technologies initiated with a Neutral at JPMorgan
03/18/20 Stifel
Keysight demand should remain healthy post-crisis, says Stifel
03/04/20 Citi
Keysight 'best and most agnostic way' to play 5G, says Citi
02/25/20 Deutsche Bank
Keysight Technologies price target raised to $130 from $125 at Deutsche Bank
KEYS Keysight Technologies
$104.35 /

+2.21 (+2.16%)

Recommendations
Piper Sandler would be buyers on Anaplan weakness following earnings » 15:02
05/26/20
05/26
15:02
05/26/20
15:02
PLAN

Anaplan

$47.42 /

-3.65 (-7.15%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLAN Anaplan
$47.42 /

-3.65 (-7.15%)

PLAN Anaplan
$47.42 /

-3.65 (-7.15%)

14:55 Today Goldman Sachs
Anaplan should benefit as macro situation improves, says Goldman Sachs
13:05 Today Rosenblatt
Rosenblatt says Anaplan reliance on large projects 'clearly impacting' business
05/21/20 RBC Capital
Anaplan price target raised to $55 from $51 at RBC Capital
05/20/20 Mizuho
Mizuho boosts Anaplan target to $50, makes top pick into Software earnings
PLAN Anaplan
$47.42 /

-3.65 (-7.15%)

PLAN Anaplan
$47.42 /

-3.65 (-7.15%)

PLAN Anaplan
$47.42 /

-3.65 (-7.15%)

Recommendations
Anaplan should benefit as macro situation improves, says Goldman Sachs » 14:55
05/26/20
05/26
14:55
05/26/20
14:55
PLAN

Anaplan

$47.88 /

-3.19 (-6.25%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLAN Anaplan
$47.88 /

-3.19 (-6.25%)

PLAN Anaplan
$47.88 /

-3.19 (-6.25%)

13:05 Today Rosenblatt
Rosenblatt says Anaplan reliance on large projects 'clearly impacting' business
05/21/20 RBC Capital
Anaplan price target raised to $55 from $51 at RBC Capital
05/20/20 Mizuho
Mizuho boosts Anaplan target to $50, makes top pick into Software earnings
05/20/20 Wells Fargo
Wells Fargo downgrades Anaplan on 'more difficult near-term setup'
PLAN Anaplan
$47.88 /

-3.19 (-6.25%)

PLAN Anaplan
$47.88 /

-3.19 (-6.25%)

PLAN Anaplan
$47.88 /

-3.19 (-6.25%)

Recommendations
Argenx price target raised to $237 from $170 at JMP Securities » 14:49
05/26/20
05/26
14:49
05/26/20
14:49
ARGX

Argenx

$214.30 /

+56.04 (+35.41%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARGX Argenx
$214.30 /

+56.04 (+35.41%)

ARGX Argenx
$214.30 /

+56.04 (+35.41%)

14:20 Today Stifel
Argenx price target raised to $253 from $163 at Stifel
11:47 Today Piper Sandler
Piper stays Overweight Alexion after Argenx data, says comps 'near impossible'
08:01 Today Stifel
Argenx's results in MG should read through positively for Momenta, says Stifel
07:35 Today Piper Sandler
Argenx price target raised to $258 from $198 at Piper Sandler
ARGX Argenx
$214.30 /

+56.04 (+35.41%)

Options
Invesco Mortgage options imply 10.8% move in share price post-earnings » 14:49
05/26/20
05/26
14:49
05/26/20
14:49
IVR

Invesco Mortgage

$2.92 /

+0.13 (+4.66%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IVR Invesco Mortgage
$2.92 /

+0.13 (+4.66%)

IVR Invesco Mortgage
$2.92 /

+0.13 (+4.66%)

06:08 Today Credit Suisse
Invesco Mortgage downgraded to Underperform from Neutral at Credit Suisse
04/08/20 JonesTrading
Invesco Mortgage downgraded to Hold from Buy at JonesTrading
IVR Invesco Mortgage
$2.92 /

+0.13 (+4.66%)

IVR Invesco Mortgage
$2.92 /

+0.13 (+4.66%)

IVR Invesco Mortgage
$2.92 /

+0.13 (+4.66%)

Conference/Events
The Cato Institute to hold a webinar » 14:45
05/26/20
05/26
14:45
05/26/20
14:45

Live Online Policy Form…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Hertz down 75% to 72c per share after reopening trade following bankruptcy news  14:43
05/26/20
05/26
14:43
05/26/20
14:43
HTZ

Hertz

$2.84 /

+ (+0.00%)

 
ShowHide Related Items >><<
HTZ Hertz
$2.84 /

+ (+0.00%)

HTZ Hertz
$2.84 /

+ (+0.00%)

05/05/20 Morgan Stanley
2020 may not be quite as bad as feared for used cars, says Morgan Stanley
04/27/20
Fly Intel: Top five analyst downgrades
04/27/20 Barclays
Barclays downgrades Hertz to Underweight on risk of capital call
04/27/20 Barclays
Hertz downgraded to Underweight from Equal Weight at Barclays
HTZ Hertz
$2.84 /

+ (+0.00%)

HTZ Hertz
$2.84 /

+ (+0.00%)

HTZ Hertz
$2.84 /

+ (+0.00%)

HTZ Hertz
$2.84 /

+ (+0.00%)

Hot Stocks
Latam Airlines down 46% to $1.40 after reopening trade following bankruptcy news  14:42
05/26/20
05/26
14:42
05/26/20
14:42
LTM

Latam Airlines

$2.57 /

+ (+0.00%)

 
ShowHide Related Items >><<
LTM Latam Airlines
$2.57 /

+ (+0.00%)

LTM Latam Airlines
$2.57 /

+ (+0.00%)

09:30 Today Raymond James
Latam Airlines downgraded to Underperform from Outperform at Raymond James
05/04/20 Deutsche Bank
Avianca downgraded to Sell from 50c price target at Deutsche Bank
04/24/20 Morgan Stanley
Latam Airlines downgraded to Underweight from Equal Weight at Morgan Stanley
04/16/20 HSBC
Latam Airlines upgraded to Buy from Hold at HSBC
LTM Latam Airlines
$2.57 /

+ (+0.00%)

LTM Latam Airlines
$2.57 /

+ (+0.00%)

LTM Latam Airlines
$2.57 /

+ (+0.00%)

Hot Stocks
LATAM Airlines trading resumes  14:38
05/26/20
05/26
14:38
05/26/20
14:38
LTM

Latam Airlines

$2.57 /

+ (+0.00%)

 
ShowHide Related Items >><<
LTM Latam Airlines
$2.57 /

+ (+0.00%)

LTM Latam Airlines
$2.57 /

+ (+0.00%)

09:30 Today Raymond James
Latam Airlines downgraded to Underperform from Outperform at Raymond James
05/04/20 Deutsche Bank
Avianca downgraded to Sell from 50c price target at Deutsche Bank
04/24/20 Morgan Stanley
Latam Airlines downgraded to Underweight from Equal Weight at Morgan Stanley
04/16/20 HSBC
Latam Airlines upgraded to Buy from Hold at HSBC
LTM Latam Airlines
$2.57 /

+ (+0.00%)

LTM Latam Airlines
$2.57 /

+ (+0.00%)

LTM Latam Airlines
$2.57 /

+ (+0.00%)

On The Fly
BioMarin seen as potential target for Sanofi following sale of Regeneron stake » 14:34
05/26/20
05/26
14:34
05/26/20
14:34
REGN

Regeneron

$537.60 /

-32.34 (-5.67%)

, SNY

Sanofi

$47.77 /

+0.46 (+0.97%)

, BMRN

BioMarin

$106.67 /

+9.17 (+9.41%)

Following the…

Open Full Text

ShowHide Related Items >><<
REGN Regeneron
$537.60 /

-32.34 (-5.67%)

SNY Sanofi
$47.77 /

+0.46 (+0.97%)

BMRN BioMarin
$106.67 /

+9.17 (+9.41%)

REGN Regeneron
$537.60 /

-32.34 (-5.67%)

10:08 Today
Fly Intel: Top five analyst upgrades
09:33 Today RBC Capital
BioMarin among Sanofi's most intriguing potential targets, says RBC Capital
09:09 Today Piper Sandler
Piper remains buyer of Regeneron, ups target to $630 on buyback accretion
08:24 Today SVB Leerink
Sanofi overhang removed, Regeneron capital structure improving, says SVB Leerink
SNY Sanofi
$47.77 /

+0.46 (+0.97%)

13:41 Today UBS
Sanofi price target lowered to EUR 101 from EUR 103 at UBS
09:09 Today Piper Sandler
Piper remains buyer of Regeneron, ups target to $630 on buyback accretion
08:24 Today SVB Leerink
Sanofi overhang removed, Regeneron capital structure improving, says SVB Leerink
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
BMRN BioMarin
$106.67 /

+9.17 (+9.41%)

09:33 Today RBC Capital
BioMarin among Sanofi's most intriguing potential targets, says RBC Capital
05/22/20 Jefferies
Jefferies adds six names to Franchise Picks list, including BioMarin and TJX
05/08/20 Canaccord
BioMarin price target raised to $119 from $108 at Canaccord
05/01/20 Jefferies
Jefferies says valrox, vosoritide uptake may be faster than other BioMarin drugs
REGN Regeneron
$537.60 /

-32.34 (-5.67%)

SNY Sanofi
$47.77 /

+0.46 (+0.97%)

BMRN BioMarin
$106.67 /

+9.17 (+9.41%)

  • 27
    May
REGN Regeneron
$537.60 /

-32.34 (-5.67%)

SNY Sanofi
$47.77 /

+0.46 (+0.97%)

REGN Regeneron
$537.60 /

-32.34 (-5.67%)

SNY Sanofi
$47.77 /

+0.46 (+0.97%)

BMRN BioMarin
$106.67 /

+9.17 (+9.41%)

REGN Regeneron
$537.60 /

-32.34 (-5.67%)

SNY Sanofi
$47.77 /

+0.46 (+0.97%)

BMRN BioMarin
$106.67 /

+9.17 (+9.41%)

Conference/Events
Upwork participates in a conference call with BTIG » 14:33
05/26/20
05/26
14:33
05/26/20
14:33
UPWK

Upwork

$12.48 /

+0.16 (+1.30%)

Software Analyst Thill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UPWK Upwork
$12.48 /

+0.16 (+1.30%)

UPWK Upwork
$12.48 /

+0.16 (+1.30%)

03/19/20 JMP Securities
Upwork price target lowered to $11 from $19 at JMP Securities
02/27/20 RBC Capital
Upwork price target lowered to $14 from $20 at RBC Capital
02/27/20 BTIG
Upwork price target lowered to $14 from $20 at BTIG
02/27/20 Cantor Fitzgerald
Upwork price target lowered to $10 from $19 at Cantor Fitzgerald
UPWK Upwork
$12.48 /

+0.16 (+1.30%)

UPWK Upwork
$12.48 /

+0.16 (+1.30%)

UPWK Upwork
$12.48 /

+0.16 (+1.30%)

Options
Boyd Gaming call volume above normal and directionally bullish » 14:25
05/26/20
05/26
14:25
05/26/20
14:25
BYD

Boyd Gaming

$20.70 /

+1.02 (+5.18%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BYD Boyd Gaming
$20.70 /

+1.02 (+5.18%)

BYD Boyd Gaming
$20.70 /

+1.02 (+5.18%)

04/29/20 Deutsche Bank
Boyd Gaming price target lowered to $22 from $42 at Deutsche Bank
04/29/20 Union Gaming
Boyd Gaming downgraded to Hold from Buy at Union Gaming
04/27/20 Nomura Instinet
Nomura sees 'attractive upside' in Boyd and Penn National as casinos reopen
04/27/20 Nomura Instinet
Boyd, Penn offer 'attractive upside' upon reopening, says Nomura Instinet
BYD Boyd Gaming
$20.70 /

+1.02 (+5.18%)

BYD Boyd Gaming
$20.70 /

+1.02 (+5.18%)

BYD Boyd Gaming
$20.70 /

+1.02 (+5.18%)

Conference/Events
Wolfe Research consumer services analyst holds analyst/industry webcast » 14:25
05/26/20
05/26
14:25
05/26/20
14:25

Consumer Services Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Roth Capital biotech analysts to hold an analyst/industry conference call » 14:25
05/26/20
05/26
14:25
05/26/20
14:25
AKRO

Akero Therapeutics

$24.92 /

+0.71 (+2.93%)

, ALT

Altimmune

$8.45 /

+1.51 (+21.76%)

, ENTA

Enanta

$55.90 /

+0.78 (+1.42%)

, GLMD

Galmed

$5.51 /

-0.29 (-5.00%)

, GNFT

Genfit

$5.26 /

+0.02 (+0.38%)

, HEPA

Hepion Pharmaceuticals

$1.94 /

-0.05 (-2.51%)

, ICPT

Intercept

$77.59 /

-2.95 (-3.66%)

, MDGL

Madrigal Pharmaceuticals

$123.16 /

-2.67 (-2.12%)

, NGM

NGM Biopharmaceuticals

$21.22 /

+1.04 (+5.15%)

Biotech Analysts, along…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AKRO Akero Therapeutics
$24.92 /

+0.71 (+2.93%)

ALT Altimmune
$8.45 /

+1.51 (+21.76%)

ENTA Enanta
$55.90 /

+0.78 (+1.42%)

GNFT Genfit
$5.26 /

+0.02 (+0.38%)

HEPA Hepion Pharmaceuticals
$1.94 /

-0.05 (-2.51%)

ICPT Intercept
$77.59 /

-2.95 (-3.66%)

MDGL Madrigal Pharmaceuticals
$123.16 /

-2.67 (-2.12%)

NGM NGM Biopharmaceuticals
$21.22 /

+1.04 (+5.15%)

AKRO Akero Therapeutics
$24.92 /

+0.71 (+2.93%)

03/31/20 H.C. Wainwright
Akero's BALANCED study results 'quite impressive,' says H.C. Wainwright
03/02/20 H.C. Wainwright
Akero Therapeutics initiated with a Buy at H.C. Wainwright
02/13/20 Roth Capital
Akero Therapeutics price target raised to $43 from $34 at Roth Capital
02/10/20 Canaccord
Akero Therapeutics initiated with a Buy at Canaccord
ALT Altimmune
$8.45 /

+1.51 (+21.76%)

05/06/20 Roth Capital
Novo data 'sets up the runway' for Altimmune, says Roth Capital
04/01/20
Roth Capital biotech analyst to hold an analyst/industry conference call
04/01/20
Roth Capital biotech analyst to hold an analyst/industry conference call
02/24/20
Fly Intel: Top five analyst initiations
ENTA Enanta
$55.90 /

+0.78 (+1.42%)

03/17/20 Baird
Baird upgrades 'defensive' Enanta, sees 'real COVID-19 potential'
03/17/20 Baird
Enanta upgraded to Outperform from Neutral at Baird
02/07/20 Roth Capital
Enanta is 'undervalued and underappreciated,' says Roth Capital
11/22/19
Fly Intel: Top five analyst downgrades
GLMD Galmed
$5.51 /

-0.29 (-5.00%)

05/22/20
Fly Intel: Top five analyst downgrades
05/22/20 B. Riley FBR
B. Riley FBR downgrades Galmed, cuts target to $8 from $11
05/22/20 B. Riley FBR
Galmed downgraded to Neutral from Buy at B. Riley FBR
05/15/20 H.C. Wainwright
Galmed price target lowered to $29 from $34 at H.C. Wainwright
GNFT Genfit
$5.26 /

+0.02 (+0.38%)

05/22/20 B. Riley FBR
Madrigal Pharmaceuticals price target raised to $174 from $134 at B. Riley FBR
05/13/20 Bryan Garnier
Genfit downgraded to Neutral from Buy at Bryan Garnier
05/13/20 Kepler Cheuvreux
Genfit downgraded to Reduce from Buy at Kepler Cheuvreux
05/12/20 B. Riley FBR
Genfit downgraded to Neutral from Buy at B. Riley FBR
HEPA Hepion Pharmaceuticals
$1.94 /

-0.05 (-2.51%)

03/20/20 Roth Capital
Roth Capital says Hepion's CRV431 could be used in COVID-19 treatment
11/22/19 Brookline
Hepion Pharmaceuticals initiated with a Buy at Brookline
11/07/19
Fly Intel: Top analyst initiations
11/07/19 Roth Capital
Hepion Pharmaceuticals initiated with a Buy at Roth Capital
ICPT Intercept
$77.59 /

-2.95 (-3.66%)

05/22/20 B. Riley FBR
Intercept weakness on 'slight' delay should be bought, says B. Riley FBR
05/22/20 Raymond James
Intercept downgraded at Raymond James after OCA NDA is postponed
05/22/20 Raymond James
Intercept downgraded to Outperform from Strong Buy at Raymond James
05/22/20 Stifel
Intercept uncertainty, lack of clarity in NASH to hurt sentiment, says Stifel
MDGL Madrigal Pharmaceuticals
$123.16 /

-2.67 (-2.12%)

05/22/20 B. Riley FBR
Madrigal Pharmaceuticals price target raised to $174 from $134 at B. Riley FBR
05/08/20 H.C. Wainwright
Madrigal Pharmaceuticals price target lowered to $168 from $215 at H.C. Wainwright
05/06/20 Goldman Sachs
Goldman says Novo Nordisk NASH data a 'clear positive' for Intercept
05/05/20 Chardan
Madrigal Pharmaceuticals initiated with a Buy at Chardan
NGM NGM Biopharmaceuticals
$21.22 /

+1.04 (+5.15%)

05/06/20 Stifel
Stifel says semaglutide data a 'slight positive' for NGM Biopharmaceuticals
04/06/20 Raymond James
NGM Biopharmaceuticals initiated with a Strong Buy at Raymond James
03/31/20 H.C. Wainwright
Akero's BALANCED study results 'quite impressive,' says H.C. Wainwright
03/27/20 Citi
NGM Biopharmaceuticals price target lowered to $28 from $34 at Citi
AKRO Akero Therapeutics
$24.92 /

+0.71 (+2.93%)

ALT Altimmune
$8.45 /

+1.51 (+21.76%)

ENTA Enanta
$55.90 /

+0.78 (+1.42%)

GLMD Galmed
$5.51 /

-0.29 (-5.00%)

ICPT Intercept
$77.59 /

-2.95 (-3.66%)

MDGL Madrigal Pharmaceuticals
$123.16 /

-2.67 (-2.12%)

NGM NGM Biopharmaceuticals
$21.22 /

+1.04 (+5.15%)

GNFT Genfit
$5.26 /

+0.02 (+0.38%)

ICPT Intercept
$77.59 /

-2.95 (-3.66%)

AKRO Akero Therapeutics
$24.92 /

+0.71 (+2.93%)

ALT Altimmune
$8.45 /

+1.51 (+21.76%)

GNFT Genfit
$5.26 /

+0.02 (+0.38%)

ICPT Intercept
$77.59 /

-2.95 (-3.66%)

MDGL Madrigal Pharmaceuticals
$123.16 /

-2.67 (-2.12%)

NGM NGM Biopharmaceuticals
$21.22 /

+1.04 (+5.15%)

AKRO Akero Therapeutics
$24.92 /

+0.71 (+2.93%)

ALT Altimmune
$8.45 /

+1.51 (+21.76%)

ICPT Intercept
$77.59 /

-2.95 (-3.66%)

NGM NGM Biopharmaceuticals
$21.22 /

+1.04 (+5.15%)

Recommendations
Argenx price target raised to $253 from $163 at Stifel » 14:20
05/26/20
05/26
14:20
05/26/20
14:20
ARGX

Argenx

$215.00 /

+56.74 (+35.85%)

Stifel analyst Derek…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARGX Argenx
$215.00 /

+56.74 (+35.85%)

ARGX Argenx
$215.00 /

+56.74 (+35.85%)

11:47 Today Piper Sandler
Piper stays Overweight Alexion after Argenx data, says comps 'near impossible'
08:01 Today Stifel
Argenx's results in MG should read through positively for Momenta, says Stifel
07:35 Today Piper Sandler
Argenx price target raised to $258 from $198 at Piper Sandler
07:08 Today Stifel
Argenx should trade up to 'mid-$180 range' after trial success, says Stifel
ARGX Argenx
$215.00 /

+56.74 (+35.85%)

Technical Analysis
NASDAQ market internals summary » 14:17
05/26/20
05/26
14:17
05/26/20
14:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 14:16
05/26/20
05/26
14:16
05/26/20
14:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.